Crixivan and Hernia - a phase IV clinical study of FDA data
Summary:
Hernia is reported as a side effect among people who take Crixivan (indinavir sulfate), especially for people who are male, 40-49 old, also take Epivir,.
The phase IV clinical study analyzes which people have Hernia when taking Crixivan. It is created by eHealthMe based on reports of 6,310 people who have side effects when taking Crixivan from the FDA, and is updated regularly.
What is Crixivan?
Crixivan has active ingredients of indinavir sulfate. eHealthMe is studying from 6,312 Crixivan users. Check the latest studies of Crixivan.
What is Hernia?
Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle) is found to be associated with 1,381 drugs and 1,484 conditions by eHealthMe. Check the latest studies of Hernia.
6,310 people reported to have side effects when taking Crixivan.
Among them, 11 people (0.17%) have Hernia.

Among these 11 people:
What is the gender of people who have Hernia when taking Crixivan? *
- female: 0.0 %
- male: 100 %
What is the age of people who have Hernia when taking Crixivan? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 75 %
- 50-59: 25 %
- 60+: 0.0 %
What are other drugs people take besides Crixivan? *
- Lamivudine: 4 people, 36.36%
- Epivir: 4 people, 36.36%
- Zerit: 3 people, 27.27%
- Stavudine: 3 people, 27.27%
- Zidovudine: 2 people, 18.18%
- Ketoconazole: 2 people, 18.18%
- Bactrim: 2 people, 18.18%
- Acyclovir: 2 people, 18.18%
- Vitamin B12: 1 person, 9.09%
- Sulfamethoprim: 1 person, 9.09%
What are other side effects people have besides Hernia? *
- Haematemesis (vomiting of blood): 3 people, 27.27%
- Splenomegaly (enlargement of spleen): 3 people, 27.27%
- Pvt: 3 people, 27.27%
- Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 3 people, 27.27%
- Oesophageal Varices (extremely dilated sub-mucosal veins in the lower third of the oesophagus): 3 people, 27.27%
- Blood In Stool: 3 people, 27.27%
- Fatty Liver: 3 people, 27.27%
- Thrombocytopenia (decrease of platelets in blood): 2 people, 18.18%
- Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 2 people, 18.18%
- Carotid Artery Stenosis (narrowing of carotid artery): 2 people, 18.18%
* Approximation only. Some reports may have incomplete information.
Do you take Crixivan and have Hernia?
- Check whether Hernia is associated with a drug or a condition (FREE)
- Predict drug outcomes for up to one year with AI (FREE)
- Get an AI agent to monitor your drugs continuously (FREE)
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Crixivan:
- Crixivan (6,312 reports)
Hernia treatments and more:
- Hernia (31,430 reports)
How severe was Hernia and when was it recovered:
Expand to all the drugs that have ingredients of indinavir sulfate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Crixivan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hernia:
- Hernia (1,381 drugs)
Browse all the conditions that are associated with Hernia:
- Hernia (1,484 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on indinavir sulfate (the active ingredients of Crixivan) and Crixivan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prochlorperazine and Eczema for Women aged 60+ - 6 seconds ago
- Prochlorperazine and Infantile Eczema for Women aged 60+ - 7 seconds ago
- Prochlorperazine and Atopic Eczema for Women aged 60+ - 7 seconds ago
- Prochlorperazine and Dermatitis - Atopic for Women aged 60+ - 7 seconds ago
- Could Azilect cause Pulmonary Embolism? - 8 seconds ago
- Migraine and Depressed Level Of Consciousness - 10 seconds ago
- Could Duobrii cause Itching? - 13 seconds ago
- Could Ribavirin cause Agitation? - 13 seconds ago
- Drug interactions of Atovaquone and Imodium - 17 seconds ago
- Methyldopa and Tachycardia Aggravated for Women aged 60+ - 19 seconds ago